Evidence map›Paper›PMID 32903610›Full record

ArticleFrontiers in immunology2020

Conventional Dendritic Cells and Slan

Marco Iannetta, Stéphane Isnard, Jennifer Manuzak, Jean-Baptiste Guillerme, Mathilde Notin, Karine Bailly, Muriel Andrieu, Sonia Amraoui, Lene Vimeux, Suzanne Figueiredo and 14 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 9 institutions in 1 country.

Marco IannettaUniversité de Paris, Institut Cochin, CNRS, INSERM, Paris, France.
Stéphane IsnardUniversité de Paris, Institut Cochin, CNRS, INSERM, Paris, France.
Jennifer ManuzakUniversité de Paris, Institut Cochin, CNRS, INSERM, Paris, France.
Jean-Baptiste GuillermeUniversité de Paris, Institut Cochin, CNRS, INSERM, Paris, France.
Mathilde NotinUniversité de Paris, Institut Cochin, CNRS, INSERM, Paris, France.
Karine BaillyUniversité de Paris, Institut Cochin, CNRS, INSERM, Paris, France.
Muriel AndrieuUniversité de Paris, Institut Cochin, CNRS, INSERM, Paris, France.
Sonia AmraouiUniversité de Paris, Institut Cochin, CNRS, INSERM, Paris, France.
Lene VimeuxUniversité de Paris, Institut Cochin, CNRS, INSERM, Paris, France.
Suzanne FigueiredoUniversité de Paris, Institut Cochin, CNRS, INSERM, Paris, France.
Bénédicte Charmeteau-de MuylderUniversité de Paris, Institut Cochin, CNRS, INSERM, Paris, France.
Laura VatonUniversité de Paris, Institut Cochin, CNRS, INSERM, Paris, France.
Etienne X HattonUniversité de Paris, Institut Cochin, CNRS, INSERM, Paris, France.
Assia SamriSorbonne Université, Inserm 1135, Centre d'Immunologie et des Maladies Infectieuses, Cimi-Paris, Paris, France.
Brigitte AutranSorbonne Université, Inserm 1135, Centre d'Immunologie et des Maladies Infectieuses, Cimi-Paris, Paris, France.
Rodolphe ThiébautINSERM, Univ. Bordeaux, CIC 1401, UMR 1219, Bordeaux Population Health Research Center, CHU Bordeaux, Bordeaux, France.
Nathalie ChaghilINSERM, Univ. Bordeaux, CIC 1401, UMR 1219, Bordeaux Population Health Research Center, CHU Bordeaux, Bordeaux, France.
David GlohiService des Maladies Infectieuses, AP-HP, Hôpital Bichat-Claude Bernard, Paris, France.
Charlotte CharpentierService des Maladies Infectieuses, AP-HP, Hôpital Bichat-Claude Bernard, Paris, France.
Diane DescampsService des Maladies Infectieuses, AP-HP, Hôpital Bichat-Claude Bernard, Paris, France.
Françoise Brun-VézinetService des Maladies Infectieuses, AP-HP, Hôpital Bichat-Claude Bernard, Paris, France.
Sophie MatheronService des Maladies Infectieuses, AP-HP, Hôpital Bichat-Claude Bernard, Paris, France.
Remi CheynierUniversité de Paris, Institut Cochin, CNRS, INSERM, Paris, France.
Anne HosmalinUniversité de Paris, Institut Cochin, CNRS, INSERM, Paris, France.
Centre National de la Recherche Scientifique · FRInserm · FRUniversité Paris Cité · FRAssistance Publique – Hôpitaux de Paris · FRCentre d'Immunologie et des Maladies Infectieuses · FRInstitut Cochin · FRBordeaux Population Health · FREcologie & Evolution · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HIV-2 infection is characterized by low viremia and slow disease progression as compared to HIV-1 infection. Circulating CD14

Indexed as

AdultAfrica, WesternAgedBiomarkersBlack PeopleCase-Control StudiesDendritic CellsEnzyme-Linked Immunosorbent AssayFemaleFlow CytometryHIV-2HIV InfectionsHIV Long-Term SurvivorsHost-Pathogen InteractionsHumansImmunophenotypingBiomarkersSECISBP2L protein, humanTumor Suppressor ProteinscDC1cDC2controlsdendritic cellsHIV-2monocytesslan+ monocytes

Identifiers

PMID32903610
PMCPMC7438582
OpenAlexW3048533612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.